SMITH ALAN E 3
3 · Candel Therapeutics, Inc. · Filed Jul 26, 2021
Insider Transaction Report
Form 3
SMITH ALAN E
Director
Holdings
- 32,548
Common Stock
Stock Option (Right to Buy)
Exercise: $1.55Exp: 2030-12-14→ Common Stock (16,274 underlying)Stock Option (Right to Buy)
Exercise: $1.46Exp: 2028-08-17→ Common Stock (4,068 underlying)Stock Option (Right to Buy)
Exercise: $6.64Exp: 2031-06-23→ Common Stock (16,274 underlying)
Footnotes (2)
- [F1]25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F2]This option is fully vested and exercisable as of the date hereof.